Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.

Vogel TJ, Dellorusso C, Welcsh P, Shah CA, Goff BA, Garcia RL, Swisher EM.

Transl Oncol. 2012 Aug;5(4):247-51. Epub 2012 Aug 1.

2.

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN.

Mod Pathol. 2005 Jan;18(1):143-52.

3.

p53 mutations and expression in ovarian cancers: correlation with overall survival.

Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF.

Int J Gynecol Pathol. 1999 Jan;18(1):29-41.

PMID:
9891239
4.

The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.

Masuya D, Huang C, Liu D, Kameyama K, Hayashi E, Yamauchi A, Kobayashi S, Haba R, Yokomise H.

Cancer. 2001 Nov 15;92(10):2628-38.

PMID:
11745198
5.

Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.

Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ.

J Natl Cancer Inst. 1998 Mar 18;90(6):447-54.

PMID:
9521169
6.

Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.

Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.

Hepatobiliary Pancreat Dis Int. 2005 May;4(2):220-6.

7.

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.

Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IeM, Kurman RJ.

Mod Pathol. 2011 Sep;24(9):1248-53. doi: 10.1038/modpathol.2011.85. Epub 2011 May 6.

8.

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.

Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ.

Cancer Res. 1993 Jul 1;53(13):3103-8.

9.

Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.

Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K.

Ann Surg Oncol. 2007 Oct;14(10):2738-47. Epub 2007 Aug 9.

PMID:
17687613
10.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
11.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
12.
13.

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.

Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.

Cancer. 2003 Jan 1;97(1):1-11.

14.

Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.

Ito T, Kaneko K, Makino R, Konishi K, Kurahashi T, Ito H, Katagiri A, Kushima M, Kusano M, Mitamura K, Imawari M.

Oncol Rep. 2003 Nov-Dec;10(6):1937-42.

PMID:
14534722
15.
16.

p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.

Shigemasa K, Hu C, West CM, Clarke J, Parham GP, Parmley TH, Korourian S, Baker VV, O'Brien TJ.

J Soc Gynecol Investig. 1997 Mar-Apr;4(2):95-102.

17.

Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.

Alvarez AA, Axelrod JR, Whitaker RS, Isner PD, Bentley RC, Dodge RK, Rodriguez GC.

Gynecol Oncol. 2001 Aug;82(2):273-8.

PMID:
11531279
18.

Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.

Miyamoto N, Yamamoto H, Taniguchi H, Miyamoto C, Oki M, Adachi Y, Imai K, Shinomura Y.

Cancer Lett. 2007 Aug 28;254(1):42-53. Epub 2007 Mar 19.

PMID:
17374440
19.

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O.

Mod Pathol. 2012 Apr;25(4):615-24. doi: 10.1038/modpathol.2011.189. Epub 2011 Dec 9.

20.

Supplemental Content

Support Center